Citation Impact
Citing Papers
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Genetic Influences on Brain Gene Expression in Rats Selected for Tameness and Aggression
2014 StandoutNobel
Glycogen Synthase Kinase 3 Inhibition Promotes Lysosomal Biogenesis and Autophagic Degradation of the Amyloid-β Precursor Protein
2012
Roles of tau protein in health and disease
2017
Acetylated Tau Neuropathology in Sporadic and Hereditary Tauopathies
2013
Synapses and Alzheimer's Disease
2012 StandoutNobel
Cell Adhesion Molecules, CREB, and the Formation of New Synaptic Connections
1996 StandoutNobel
Aberrant β-Catenin Signaling in Tuberous Sclerosis
2005
The Tuberous Sclerosis Complex
2006 Standout
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism
2005
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
2007 Standout
Apolipoprotein E receptor 2 is involved in neuritic plaque formation in APP sw mice
2004
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Neuroplasticity Mediated by Altered Gene Expression
2007
Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
1994 Standout
The role of autophagy in neurodegenerative disease
2013 Standout
Glutamate uptake
2001 Standout
The use of the hippocampal slice preparation in the study of Alzheimer's disease
2008
Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by β-amyloid fibrils
2003
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
2007 Standout
Alzheimer's disease
2011 Standout
Amyloidosis and Alzheimer’s disease
2002
WNT and β-catenin signalling: diseases and therapies
2004 Standout
Cell-adhesion molecules, glucocorticoids and long-term-memory formation
1995
Overactivation of glycogen synthase kinase‐3 by inhibition of phosphoinositol‐3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory
2003
A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
2009
Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology
1992
Iron (III) induces aggregation of hyperphosphorylated τ and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease
2002
Amyloid Precursor Protein (APP) and ΒZA4 Amyloid in the Etiology of Alzheimer's Disease: Precursor‐Product Relationships in the Derangement of Neuronal Function
1991
Secreted Form of Amyloid Precursor Protein Enhances Basal Glucose and Glutamate Transport and Protects Against Oxidative Impairment of Glucose and Glutamate Transport in Synaptosomes by a Cyclic GMP‐Mediated Mechanism
1999
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
2014
Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418
2003
Parkinson's disease
2009 Standout
Increased expression of Wnt-1 in schizophrenic brains
1999
Tau in physiology and pathology
2015 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Mechanisms of Postnatal Neurobiological Development: Implications for Human Development
2001
Re-evaluation of the linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the Old Order Amish
1989 StandoutNature
Increase in extracellular NCAM and amyloid precursor protein following induction of long-term potentiation in the dentate gyrus of anaesthetized rats
1994
Early sequential formation of functional GABAA and glutamatergic synapses on CA1 interneurons of the rat foetal hippocampus
2002
Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts
1997
Presenilins and APP in Neuritic and Synaptic Plasticity: Implications for the Pathogenesis of Alzheimer's Disease
2002
Beta amyloid precursor protein mediates neuronal cell‐cell and cell‐surface adhesion
1991
Glycogen synthase kinase 3: a drug target for CNS therapies
2004
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
1995 Standout
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
2009 Standout
Parkinson's disease
2015 Standout
Neurovascular regulation in the normal brain and in Alzheimer's disease
2004 Standout
Molecular mechanisms of neurodegeneration in Alzheimer's disease
2010
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
Increased level of active GSK‐3β in Alzheimer’s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration
2007
Depressive symptoms, sex, and risk for Alzheimer's disease
2005
Microtubule‐associated proteins in developing oligodendrocytes: Transient expression of a MAP2c isoform in oligodendrocyte precursors
1995
GSK-3 and the neurodevelopmental hypothesis of schizophrenia
2002
Does Lithium Prevent Alzheimerʼs Disease?
2012
The Unfolded Protein Response Is Activated in Pretangle Neurons in Alzheimer's Disease Hippocampus
2009
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer’s disease and tauopathies to granulovacuolar degeneration bodies
2006
Neuropathological Alterations in Alzheimer Disease
2011 Standout
The sequential hypothesis on sleep function. II. A correlative study between sleep variables and newly synthesized brain DNA
1988
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
The Role of Synaptic Proteins in the Pathogenesis of Disorders of the Central Nervous System
1993
Alzheimer's Disease
2010 Standout
Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory
2003
Huntington's disease is a four-repeat tauopathy with tau nuclear rods
2014
Possible Causes of Alzheimer's Disease: Amyloid Fragments, Free Radicals, and Calcium Homeostasis
1998
The Amyloid State of Proteins in Human Diseases
2012 Standout
LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β
2007
The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases
1995
Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology
2008
AKT/PKB Signaling: Navigating the Network
2017 Standout
The ups and downs of Wnt signaling in prevalent neurological disorders
2006
Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
2012 StandoutNobel
Parkinson's Disease and Parkinsonism: Neuropathology
2012
Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus
2010
Tau Protein Is Required for Amyloid β-Induced Impairment of Hippocampal Long-Term Potentiation
2011
The sequential hypothesis on sleep function. I. Evidence that the structure of sleep depends on the nature of the previous waking experience
1988
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
2006 Standout
Why sex matters for neuroscience
2006 Standout
GSK-3: Functional Insights from Cell Biology and Animal Models
2011
Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions
2006
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
2012 Standout
Dystrophic neurites of senile plaques in Alzheimer’s disease are deficient in cytochrome c oxidase
2008
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies
2012
Antibodies against β‐amyloid reduce aβ oligomers, glycogen synthase kinase‐3β activation and τ phosphorylation in vivo and in vitro
2005
Excitatory actions of gaba during development: the nature of the nurture
2002 Standout
Developmental potential in the first 5 years for children in developing countries
2007 Standout
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
A Genome-Wide Association Study of Neuroticism in a Population-Based Sample
2010
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
The molecular pathology of Alzheimer's disease
1991 Standout
Development of Beta-Amyloid-induced Neurodegeneration in Alzheimer's Disease and Novel Neuroprotective Strategies
2005
Comprehensive qPCR profiling of gene expression in single neuronal cells
2011 StandoutNobel
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
2003
Aging Analysis Reveals Slowed Tau Turnover and Enhanced Stress Response in a Mouse Model of Tauopathy
2008
Post-translational modifications of tau protein: Implications for Alzheimer's disease
2011
Mutation in the Phosphorylation Sites of MAP Kinase Blocks Learning-Related Internalization of apCAM in Aplysia Sensory Neurons
1997 StandoutNobel
Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP
2010 StandoutNobel
GluN2B subunit-containing NMDA receptor antagonists prevent Aβ-mediated synaptic plasticity disruption in vivo
2009
Tau alternative splicing in familial and sporadic tauopathies
2012
Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
2015
The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system
1995
Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides
2009
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degenerationin vivo
2005
Mutations causing neurodegenerative tauopathies
2004
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
1993 Standout
Alzheimer's Disease: Genes, Proteins, and Therapy
2001 Standout
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
About Sleep's Role in Memory
2013 Standout
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
2005 StandoutScience
Role of Tau Protein in Both Physiological and Pathological Conditions
2004
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
2003
A Phase II Trial of Tideglusib in Alzheimer's Disease
2015
Molecular genetic evidence for heterogeneity in manic depression
1987 Nature
Lithium Treatment Arrests the Development of Neurofibrillary Tangles in Mutant Tau Transgenic Mice with Advanced Neurofibrillary Pathology
2010
Wnt signaling function in Alzheimer’s disease
2000
Works of Brian Anderton being referenced
Tau binds to phosphatidylinositol-3-kinase, GRB2 phospholipase C gamma-1 and SRC-family kinases through SH3 domain
2002
Synaptophysin and chromogranin A immunoreactivities in senile plaques of Alzheimer's disease
1991
Intraventricular infusions of antibodies to amyloid-β-protein precursor impair the acquisition of a passive avoidance response in the rat
1990
First one in, last one out: the role of GABAergic transmission in generation and degeneration
1998
The active form of glycogen synthase kinase-3? is associated with granulovacuolar degeneration in neurons in Alzheimer's disease
2002
Chromosome 13 dementia syndromes as models of neurodegeneration
2001
Glycogen synthase kinase‐3 inhibition is integral to long‐term potentiation
2007
Abnormalities of Wnt signalling in schizophrenia – evidence for neurodevelopmental abnormality
1998
Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau
2011
Microtubule-associated proteins MAP5 and MAP1x: closely related components of the neuronal cytoskeleton with different cytoplasmic distributions in the developing brain
1989
Glycogen synthase kinase-3β immunoreactivity is reduced in the prefrontal cortex in schizophrenia
2001
Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex
1999
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule‐binding repeat domains as demonstrated by new specific monoclonal antibodies
2003
Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease
2004
Aluminium-induced tangles in cultured rat neurones
1990
Cytoskeletal abnormalities in Alzheimer's disease.
1992
Characterization of a partial cDNA specific for the high molecular weight microtubule-associated protein MAP2 that encodes epitopes shared with paired helical filaments of Alzheimer's disease
1990
Role of RNA and DNA in Brain Function: a Molecular Biological Approach
1987